Obstetrics & Gynecology Doctors in Huntington Station, NY Accepting Medicare

6 Obstetrics & Gynecology doctors found. Showing 1 - 6

Karen Ann Moriarty-morris, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 180 E Pulaski Rd, Huntington Station, NY 11746 Phone: 631-425-2218    Fax: 631-425-2173

Gerald M. Siegel, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 180 E Pulaski Rd, Huntington Station, NY 11746 Phone: 631-425-2121    Fax: 631-425-2193

Phyllis Simon, MD Obstetrics & Gynecology - Gynecology Medicare: Not Enrolled in Medicare Practice Location: 180 E Pulaski Rd, Huntington Station, NY 11746 Phone: 631-425-2121    Fax: 631-425-2193

Elisa C Felsen-singer, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 180 E Pulaski Rd, Huntington Station, NY 11746 Phone: 631-425-2218    Fax: 631-425-2173

Mitchell S Kramer, MD Obstetrics & Gynecology - Obstetrics Medicare: Accepting Medicare Assignments Practice Location: 180 E Pulaski Rd, Huntington Station, NY 11746 Phone: 631-425-2218    Fax: 631-425-2173

Dr. Sharon Cote, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 180 E Pulaski Rd, Huntington Station, NY 11746 Phone: 631-425-2218    Fax: 631-425-2173

News Archive

Seroquel XR's FDA approval does not change Decision Resources' earlier antipsychotics market forecast

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that the recent decision by the U.S. Food and Drug Administration (FDA) to grant approval of AstraZeneca's Seroquel XR for adjunctive treatment of major depressive disorder will not change Decision Resources' market forecast for the indication. As previously forecasted, Seroquel and Seroquel XR will garner nearly one quarter of antipsychotics sales as adjunctive treatments for major depressive disorder in 2013 in the world's major pharmaceutical markets.

AngioDynamics introduces redesigned Centros self-centering chronic hemodialysis access catheter

AngioDynamics announced today it has achieved the national launch of the newly redesigned Centros self-centering, chronic hemodialysis access catheter.

Molecular Health granted European patent for novel Erythropoietin receptor

Molecular Health announced today it has been granted a patent in Europe entitled "Tissue Protective Erythropoietin Receptor". This latest patent supports Molecular Health's discovery that EPHB4 is a novel receptor for Erythropoietin (EPO), where EPHB4 binds to EPO and promotes tumor growth.

Auxilium, FCB I file suit against Watson over generic Testim

Watson Pharmaceuticals, Inc. today confirmed that its subsidiary, Watson Laboratories, Inc., filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) seeking approval to market Testosterone Gel, 1%. Watson's 1% testosterone gel product is a generic version of Auxilium Pharmaceuticals, Inc.'s Testim 1%.

Researchers show for first time that brain can control core body temperature

A team of researchers led by Associate Professor Maria Kozhevnikov from the Department of Psychology at the National University of Singapore Faculty of Arts and Social Sciences showed, for the first time, that it is possible for core body temperature to be controlled by the brain.

Read more Medical News

› Verified 4 days ago